193 related articles for article (PubMed ID: 28251953)
41. Crystal structure of active site mutant of antileukemic L-asparaginase reveals conserved zinc-binding site.
Borek D; Kozak M; Pei J; Jaskolski M
FEBS J; 2014 Sep; 281(18):4097-111. PubMed ID: 25040257
[TBL] [Abstract][Full Text] [Related]
42. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.
Nguyen HA; Su Y; Lavie A
J Biol Chem; 2016 Aug; 291(34):17664-76. PubMed ID: 27354283
[TBL] [Abstract][Full Text] [Related]
43. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
Kumar S; Venkata Dasu V; Pakshirajan K
Bioresour Technol; 2011 Jan; 102(2):2077-82. PubMed ID: 20832300
[TBL] [Abstract][Full Text] [Related]
44. Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity--An in silico Approach.
Ramya LN; Pulicherla KK
Pathol Oncol Res; 2015 Sep; 21(4):909-20. PubMed ID: 25740072
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a novel asparaginase from soil metagenomic libraries generated from forest soil.
Arjun JK; Aneesh BP; Kavitha T; Harikrishnan K
Biotechnol Lett; 2018 Feb; 40(2):343-348. PubMed ID: 29127643
[TBL] [Abstract][Full Text] [Related]
46. Enhanced catalysis of L-asparaginase from Bacillus licheniformis by a rational redesign.
Sudhir AP; Agarwaal VV; Dave BR; Patel DH; Subramanian RB
Enzyme Microb Technol; 2016 May; 86():1-6. PubMed ID: 26992786
[TBL] [Abstract][Full Text] [Related]
47. Crystallization and preliminary crystallographic analysis of L-asparaginase from Erwinia carotovora.
Wikman LE; Krasotkina J; Kuchumova A; Sokolov NN; Papageorgiou AC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Apr; 61(Pt 4):407-9. PubMed ID: 16511054
[TBL] [Abstract][Full Text] [Related]
48. A Newly Identified Glutaminase-Free ʟ-Asparaginase (ʟ-ASPG86) from the Marine Bacterium Mesoflavibacter zeaxanthinifaciens.
Lee SJ; Lee Y; Park GH; Umasuthan N; Heo SJ; De Zoysa M; Jung WK; Lee DW; Kim H; Kang DH; Oh C
J Microbiol Biotechnol; 2016 Jun; 26(6):1115-23. PubMed ID: 26975773
[TBL] [Abstract][Full Text] [Related]
49. A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant.
Palm GJ; Lubkowski J; Derst C; Schleper S; Röhm KH; Wlodawer A
FEBS Lett; 1996 Jul; 390(2):211-6. PubMed ID: 8706862
[TBL] [Abstract][Full Text] [Related]
50. High yield expression of novel glutaminase free L-asparaginase II of Pectobacterium carotovorum MTCC 1428 in Bacillus subtilis WB800N.
Chityala S; Venkata Dasu V; Ahmad J; Prakasham RS
Bioprocess Biosyst Eng; 2015 Nov; 38(11):2271-84. PubMed ID: 26440965
[TBL] [Abstract][Full Text] [Related]
51. Effect of surface charge alteration on stability of L-asparaginase II from Escherichia sp.
Vidya J; Ushasree MV; Pandey A
Enzyme Microb Technol; 2014 Mar; 56():15-9. PubMed ID: 24564897
[TBL] [Abstract][Full Text] [Related]
52. Proteins from Erwinia asparaginase Erwinase ® and E. coli asparaginase 2 MEDAC ® for treatment of human leukemia, show a multitude of modifications for which the consequences are completely unclear.
Bae N; Pollak A; Lubec G
Electrophoresis; 2011 Jul; 32(14):1824-8. PubMed ID: 21769889
[TBL] [Abstract][Full Text] [Related]
53. Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis.
Ramirez-Paz J; Saxena M; Delinois LJ; Joaquín-Ovalle FM; Lin S; Chen Z; Rojas-Nieves VA; Griebenow K
PLoS One; 2018; 13(7):e0197643. PubMed ID: 30052638
[TBL] [Abstract][Full Text] [Related]
54. Isolation, Purification, Characterisation and Application of L-ASNase: A Review.
Paul T; Mondal A; Bandyopadhyay TK
Recent Pat Biotechnol; 2019; 13(1):33-44. PubMed ID: 30318009
[TBL] [Abstract][Full Text] [Related]
55. Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis.
Derst C; Henseling J; Röhm KH
Protein Eng; 1992 Dec; 5(8):785-9. PubMed ID: 1287659
[TBL] [Abstract][Full Text] [Related]
56. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes].
Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947
[TBL] [Abstract][Full Text] [Related]
57. Development of medium for enhanced production of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
Kumar S; Pakshirajan K; Venkata Dasu V
Appl Microbiol Biotechnol; 2009 Sep; 84(3):477-86. PubMed ID: 19352649
[TBL] [Abstract][Full Text] [Related]
58. A potential type-II L-asparaginase from marine isolate Bacillus australimaris NJB19: Statistical optimization, in silico analysis and structural modeling.
Chakravarty N; Priyanka ; Singh J; Singh RP
Int J Biol Macromol; 2021 Mar; 174():527-539. PubMed ID: 33508362
[TBL] [Abstract][Full Text] [Related]
59. Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.
Derst C; Henseling J; Röhm KH
Protein Sci; 2000 Oct; 9(10):2009-17. PubMed ID: 11106175
[TBL] [Abstract][Full Text] [Related]
60. Studies on pH and thermal stability of novel purified L-asparaginase from Pectobacterium carotojorum MTCC 1428.
Kumar S; Dasu VV; Pakshirajan K
Mikrobiologiia; 2011; 80(3):349-55. PubMed ID: 21861371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
